Beckman Coulter teams with Flownamics on bioprocess culture monitoring August 24, 2022 -- Beckman Coulter Life Sciences has partnered with Flownamics to offer an automated, online solution for bioprocess culture monitoring and control, meeting what the companies see as an unmet need in the current bioprocessing environment.Read More
Alzheimer’s disease and modifiable risk factors: Genetic associations revealed May 17, 2023 -- A genetic association study comparing participants with Alzheimer’s disease and control participants without Alzheimer’s disease found novel genetic associations between high high-density lipoprotein (HDL) cholesterol concentrations and high systolic blood pressure and a higher risk of Alzheimer’s disease.Read More
At SLAS 2023, companies showcase, launch advanced automation and screening technologies February 28, 2023 -- At the Society for Laboratory Automation and Screening (SLAS) 2023 International Conference and Exhibition, being held in San Diego from February 25 to March 1, numerous firms have announced that they are showcasing emerging technologies for advanced life science applications.Read More
Beckman Coulter, Sciex collaborate on high-throughput screening workflows February 27, 2023 -- Life science analytical technologies company Sciex on Monday announced a collaboration with Beckman Coulter Life Sciences to provide comprehensive workflows for high-throughput screening; high-throughput absorption, distribution, metabolism, and excretion (HT-ADME); and synthetic biology studies.Read More
Heart problems more likely among long COVID patients in comprehensive study February 23, 2023 -- Individuals with long COVID were found to have more than double the risk of developing new cardiovascular symptoms. The results of a comprehensive study examining cardiovascular complications from long COVID will be presented at the American College of Cardiology Together with the World Congress of Cardiology (ACC.23/WCC) conference. The event, marking the ACC’s 72nd Annual Scientific Session, will take place March 4-6, both online and in New Orleans.Read More
FDA issues draft guidance for implementing decentralized clinical trials May 2, 2023 -- The U.S. Food and Drug Administration (FDA) on Tuesday said that it is taking additional steps to support the use of decentralized clinical trials (DCTs) for drugs, biologics, and devices, where some or all the trial-related activities occur at locations other than traditional clinical trial sites.Read More
Specialized printer may help vaccines reach more people April 24, 2023 -- Researchers have developed a specialized printer to generate vaccine-filled microneedle skin patches that can be stored long-term without refrigeration. Their research, published Monday in Nature Biotechnology, may eventually bring more vaccines to more people.Read More
An unprecedented view of gene regulation May 8, 2023 -- Massachusetts Institute of Technology (MIT) engineers have developed a technique to analyze the organization of the genome at a resolution 100 times higher than was previously possible.Read More
Boosting TERRA levels damages DNA of hard-to-kill cancer cells: study September 20, 2022 -- Increasing levels of telomeric repeat-containing RNA (TERRA) damages the DNA of cancers with a particular form of replicative immortality and leads to cell death, according to Portuguese researchers who show that “anti-aging clocks” can be used to kill cancer cells.Read More
Ga. researchers combine DNA barcoding, target sequencing July 5, 2022 -- Researchers in Georgia have developed a system to make preclinical nanoparticle studies more predictive that combines DNA barcoding with a multiomic nanoparticle delivery system called single-cell nanoparticle targeting-sequencing.Read More